Data-driven multiple-level analysis of gut-microbiome-immune-joint interactions in rheumatoid arthritis
- PMID: 30744546
- PMCID: PMC6371598
- DOI: 10.1186/s12864-019-5510-y
Data-driven multiple-level analysis of gut-microbiome-immune-joint interactions in rheumatoid arthritis
Abstract
Background: Rheumatoid arthritis (RA) is the most common autoimmune disease and affects about 1% of the population. The cause of RA remains largely unknown and could result from a complex interaction between genes and environment factors. Recent studies suggested that gut microbiota and their collective metabolic outputs exert profound effects on the host immune system and are implicated in RA. However, which and how gut microbial metabolites interact with host genetics in contributing to RA pathogenesis remains unknown. In this study, we present a data-driven study to understand how gut microbial metabolites contribute to RA at the genetic, functional and phenotypic levels.
Results: We used publicly available disease genetics, chemical genetics, human metabolome, genetic signaling pathways, mouse genome-wide mutation phenotypes, and mouse phenotype ontology data. We identified RA-associated microbial metabolites and prioritized them based on their genetic, functional and phenotypic relevance to RA. We evaluated the prioritization methods using short-chain fatty acids (SCFAs), which were previously shown to be involved in RA etiology. We validate the algorithms by showing that SCFAs are highly associated with RA at genetic, functional and phenotypic levels: SCFAs ranked at top 3.52% based on shared genes with RA, top 5.69% based on shared genetic pathways, and top 16.94% based on shared phenotypes. Based on the genetic-level analysis, human gut microbial metabolites directly interact with many RA-associated genes (as many as 18.1% of all 166 RA genes). Based on the functional-level analysis, human gut microbial metabolites participate in many RA-associated genetic pathways (as many as 71.4% of 311 genetic pathways significantly enriched for RA), including immune system pathways. Based on the phenotypic-level analysis, gut microbial metabolites affect many RA-related phenotypes (as many as 51.3% of 978 phenotypes significantly enriched for RA), including many immune system phenotypes.
Conclusions: Our study demonstrates strong gut-microbiome-immune-joint interactions in RA, which converged on both genetic, functional and phenotypic levels.
Keywords: Computational analysis; Gut microbiota; Metabolism; Rheumatoid arthritis.
Conflict of interest statement
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
Gut-microbiota-microglia-brain interactions in Alzheimer's disease: knowledge-based, multi-dimensional characterization.Alzheimers Res Ther. 2021 Oct 20;13(1):177. doi: 10.1186/s13195-021-00917-1. Alzheimers Res Ther. 2021. PMID: 34670619 Free PMC article.
-
Interactions between Gut Microbiota and Immunomodulatory Cells in Rheumatoid Arthritis.Mediators Inflamm. 2020 Sep 9;2020:1430605. doi: 10.1155/2020/1430605. eCollection 2020. Mediators Inflamm. 2020. PMID: 32963490 Free PMC article. Review.
-
Gut microbiota and their metabolites in the immune response of rheumatoid arthritis: Therapeutic potential and future directions.Int Immunopharmacol. 2025 Feb 6;147:114034. doi: 10.1016/j.intimp.2025.114034. Epub 2025 Jan 12. Int Immunopharmacol. 2025. PMID: 39805176 Review.
-
Exploring the significance of microbiota metabolites in rheumatoid arthritis: uncovering their contribution from disease development to biomarker potential.APMIS. 2024 Jun;132(6):382-415. doi: 10.1111/apm.13401. Epub 2024 Mar 12. APMIS. 2024. PMID: 38469726 Review.
-
A systems biology approach to predict and characterize human gut microbial metabolites in colorectal cancer.Sci Rep. 2018 Apr 18;8(1):6225. doi: 10.1038/s41598-018-24315-0. Sci Rep. 2018. PMID: 29670137 Free PMC article.
Cited by
-
CoMNRank: An integrated approach to extract and prioritize human microbial metabolites from MEDLINE records.J Biomed Inform. 2020 Sep;109:103524. doi: 10.1016/j.jbi.2020.103524. Epub 2020 Aug 11. J Biomed Inform. 2020. PMID: 32791237 Free PMC article.
-
Gut-microbiota-microglia-brain interactions in Alzheimer's disease: knowledge-based, multi-dimensional characterization.Alzheimers Res Ther. 2021 Oct 20;13(1):177. doi: 10.1186/s13195-021-00917-1. Alzheimers Res Ther. 2021. PMID: 34670619 Free PMC article.
-
Automatic extraction, prioritization and analysis of gut microbial metabolites from biomedical literature.Sci Rep. 2020 Jun 19;10(1):9996. doi: 10.1038/s41598-020-67075-6. Sci Rep. 2020. PMID: 32561832 Free PMC article.
-
Airway microbiome-immune crosstalk in chronic obstructive pulmonary disease.Front Immunol. 2023 Jan 17;13:1085551. doi: 10.3389/fimmu.2022.1085551. eCollection 2022. Front Immunol. 2023. PMID: 36741369 Free PMC article. Review.
-
Fatty Acids and Oxylipins in Osteoarthritis and Rheumatoid Arthritis-a Complex Field with Significant Potential for Future Treatments.Curr Rheumatol Rep. 2021 Apr 28;23(6):41. doi: 10.1007/s11926-021-01007-9. Curr Rheumatol Rep. 2021. PMID: 33913032 Free PMC article. Review.
References
MeSH terms
Grants and funding
- R01 AG061388-01/AG/NIA NIH HHS/United States
- UL1 TR002548/TR/NCATS NIH HHS/United States
- DP2 HD084068/HD/NICHD NIH HHS/United States
- R56 AG062272/AG/NIA NIH HHS/United States
- R01 AG061388/AG/NIA NIH HHS/United States
- DP2HD084068/Eunice Kennedy Shriver National Institute of Child Health and Human Development
- WI206753/Pfizer
- R56 AG062272-01/AG/NIA NIH HHS/United States
- 1UL1TR002548-01/NH/NIH HHS/United States
- R01 EY029297/EY/NEI NIH HHS/United States
- R01 AG057557-01/AG/NIA NIH HHS/United States
- R01 AG057557/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical